Pharmaceutical Executive Europe - IMS Oncology Supplement September 2007 - (Page 2)

Contents Market View Riding the Wave Graham Lewis The developments and breakthroughs of the last ten years have created a golden age for oncology. So what lies ahead? page 3 Economics Zero Sum Game Pamela Santoni and Thomas Foster The economic climate for cancer is ‘hot,’ but that could threaten its future. How can drug companies keep up with this ‘progress’? page 6 Healthy Outlook? I n this Focus on Oncology, Graham Lewis, Pamela Santoni and Thomas Foster of IMS Health look at a market that has — from the surge of new product introductions in 1997 and the launch of Herceptin in 1998 — seen 10 years of remarkable breakthroughs and developments. Graham reports that, in many ways, this is oncology’s golden age. Certainly, the figures bear this out: global sales reached $35 billion last year, with targeted therapies accounting for $13 billion. Pamela Santoni and Thomas Foster, however, temper the good news with a warning of the challenges of such an increasingly crowded and competitive market. Indeed, pharma companies wishing to sustain their oncology success cannot afford to be complacent. It is time to start devising new business models that prepare them for what is bound to be another interesting decade. Julian Upton Group Publisher Dean Graimes Tel. +44 1244 393 408 Editorial Director David Hills Tel. +44 1244 393 256 Editor Julian Upton Assistant Editor Victoria Farrell Sales Support Claire Rice Graphic Designer Ian Williams Production Director Jo Armstrong Repro Art Worker Alan James Advanstar Communications Inc. Chief Executive Officer Joseph Loggia Chief Financial Officer Theodore S. Alpert Chief Marketing Officer Patricia Joseph Executive VP, Corporate Development Eric I. Lisman VP, Treasurer & Controller Adele D. Hartwick VP, Publishing Operations Francis Heid VP, Human Resources Nancy Nugent Pharmaceutical Executive Pharmaceutical Executive Europe provides industry intelligence so managers in the European pharmaceutical community can advance their business, management and marketing practices to gain competitive advantage. PEE interprets the current and future challenges the industry faces and enables pharmaceutical professionals to overcome them with costeffective, time-saving solutions. Group Marketing Manager Helen Taylor Marketing Manager Sally Carron Senior Sales Executive Richard Hodson Advanstar Communications (U.K.) Ltd Managing Director Helen Gardner Corporate Office Advanstar Communications Inc. 7500 Old Oak Boulevard Cleveland OH 44130, USA VP, Chief Technology Officer Rick Treese VP, Marketing & Communications Georgiann Decenzo VP, General Counsel Ward Hewins Subscribe online at Pharmaceutical Executive Europe is free to qualified subscribers in Europe. To apply for a free subscription, or to change your name or address, go to, click on Subscribe, & follow the prompts. To cancel your subscription or to order back issues, please email your request to, putting PEE in the subject line. Please quote your subscription number if you have it Non-qualified readers in Europe Readers outside Europe 1 year (8 issues) £100 £140 2 years (16 issues) £170 £240 Current issue: Back issue: £20 £35 Copyright ©2007. Advanstar Communications (UK) Ltd. All rights reserved. No part of this publication may be reproduced in any material form (including photocopying or storing it in any medium by electronic means and whether or not transiently or incidentally to some other use of this publication) without the written permission of the copyright owner except in accordance with the provisions of the Copyright, Designs & Patents Act (UK) 1988 or under the terms of a licence issued by the Copyright Licensing Agency, 90 Tottenham Court Road, London W1P 0LP, UK. Applications for the copyright owner’s permission to reproduce any part of this publication should be forwarded in writing to Permissions Dept, Advanstar Communications (UK) Ltd, Advanstar House, Park West, Sealand Road, Chester CH1 4RN, UK. Warning: The doing of an unauthorized act in relation to a copyright work may result in both a civil claim for damages and criminal prosecution. 2 SEPTEMBER 2007 ONCOLOGY

Table of Contents for the Digital Edition of Pharmaceutical Executive Europe - IMS Oncology Supplement September 2007

Riding the Wave
Zero Sum Game

Pharmaceutical Executive Europe - IMS Oncology Supplement September 2007